Hereditary Angioedema Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Hereditary Angioedema Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : October, 2020 | Pharmaceutical | PPT format

Report Digest


Global Hereditary Angioedema Market: An Overview

Hereditary angioedema develops in the most common areas of the body and results in recurrent episodes of severe swelling. The condition affects intestinal tract, limbs, and airways. Moreover, episodes of trauma, can trigger an attack, but the probable cause of these are still yet unconfirmed. The condition results in fatalities for one-third of the people, and can progress into a rash called arythema marginatum during an attack. There are three types of hereditary angioedema. Among these, type I is the most common condition, and affects over 85% of patients, while type II affects nearly 15%. Type III is most rare among them all. The condition affects over 1 in 50,000 people, and its growing awareness is expected to drive growth for players in the hereditary angioedema market. Recent technological advancements including Big Data, and data analysis are expected to open new opportunities for growth in the hereditary angioedema market in the near future.

Global Hereditary Angioedema Market: Notable Developments

BioCryst Pharmaceuticals has submitted a new drug application to the FDA for approval of Berotralstat. The oral and daily dose of this medicine has been tested and promises to prevent swelling attacks in patients for a year. The drug highly needed for the hereditary angioedema condition has shown promising results in ApeX-2, and Apex-S trials that it is safe and effective while lowering mean attack rates from three to one or fewer per month.

Growing awareness about genetic mutations, and initiative for protecting new-borns against genetic illnesses are expected to result in further regulatory support in the US. Currently, legislation in senate named the Newborn Screeing Saves Lives Reauthorization, promises awaits senate vote. If passed, the bill will provide $60 million yearly funding to states to enact newborn screening programs. The new programs with the help of the National Academy of Medicine, will drive growth of implementation, and make recommendation for new ones. Currently, the yearly funding stands at $20 million a year. The rising awareness about genetic illnesses, and growing support in the senate will likely drive growth for players in the hereditary angioedema market.

Global Hereditary Angioedema Market: Drivers and Restraints

The global hereditary angioedema market is likely to witness major growth as rising genetic screening, and technological advancements like Big Data continue to result in better diagnosis, and more treatment. Moreover, growing support for regulatory bodies like the FDA for rare conditions, and legislations like Newborn Screening Saves Lives Reauthorization also promise new opportunities for expansions in key markets. Moreover, various pharmaceutical companies are investing in innovation as expiry of various patents, increased regulatory support for innovation, and reducing costs for innovations due to outsourcing of various operations continues to drive growth for players in the hereditary angioedema market.

Global Hereditary Angioedema Market: Geographical Outlook

The global hereditary angioedema market report will cover all key regions of the globe including North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Among these, North America and Europe are likely to witness major growth, thanks to new drug approvals, growing investment in innovation, and promising horizons of drug development with technological advancements like 3D printing among others. The global hereditary angioedema market in Asia pacific will also witness substantial growth as countries like China, and the promising push of the Chinese FDA for innovation promises new opportunities for regional players. Moreover, expanding access to healthcare, promising innovation in countries like India, and Japan, and rising disposable income are likely to drive new opportunities for growth in the hereditary angioedema market during the forecast period.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?